ro7790121
Small moleculeexperimental
Clinical trial activity
6 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
5
Phase 3
4
Phase 4
0
Earliest trial started Sep 17, 2024 (NCT06589986)
Timeline
Indications
Mechanism of action
TNFSF15 modulator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06819891 | Phase 3 | Apr 30, 2025 | Chugai, Roche |
| NCT06903065 | Phase 1 | Apr 14, 2025 | Roche |
| NCT06863961 | Phase 2 | Mar 14, 2025 | Roche |
| NCT06819878 | Phase 3 | Mar 10, 2025 | Chugai, Roche |
| NCT06588855 | Phase 3 | Dec 31, 2024 | Roche |
| NCT06589986 | Phase 3 | Sep 17, 2024 | Chugai, Roche |
Showing 6 of 6 trials
Page 1 / 1